Information  X 
Enter a valid email address

Accrol Group Hldgs (ACRL)

  Print      Mail a friend

Friday 01 June, 2018

Accrol Group Hldgs

Placing Shares Admitted and Total Voting Rights

RNS Number : 8738P
Accrol Group Holdings PLC
01 June 2018

1 June 2018




Placing Shares Admitted and Total Voting Rights


Accrol Group Holdings plc ("Accrol" or the "Company"), the leading independent tissue converter in the UK, notes that the 53,333,334 new ordinary shares issued pursuant to the recently announced Placing to raise £8.0 million have been admitted to trading earlier today ("Admission"). 


Following Admission, there are 182,345,336 ordinary shares of £0.001 in the capital of Accrol in issue, with one voting right each. The Company does not hold any shares in treasury. The number of Ordinary Shares with voting rights is therefore 182,345,336. Accordingly, this number should be used by shareholders as the denominator for the calculations by which they will determine if they are required to notify their interest in, or a change to their interest in, the Company under the FCA's Disclosure and Transparency Rules.




Zeus Capital Limited (Nominated Adviser & Broker)


Dan Bate / Andrew Jones                                                                  

Tel: +44 (0) 161 831 1512

Dominic King / John Goold                                                                     

Tel: +44 (0) 203 829 5000



Belvedere Communications Limited                                          


Cat Valentine

Mob: +44 (0) 7715 769 078


Notes to Editors


Accrol Group Holdings plc, based in Lancashire, is a leading tissue converter and supplier of toilet rolls, kitchen rolls and facial tissues as well as other tissue products to major retailers throughout the UK. 


Accrol operates from three sites:


·      A manufacturing, storage and distribution facility in Blackburn;

·      A facial tissue plant, also in Blackburn; and

·      A manufacturing, storage and distribution facility in Leyland.



This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [email protected] or visit

a d v e r t i s e m e n t